These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient. Murphy C; Hawkes E; Chionh F; Chong G J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727 [TBL] [Abstract][Full Text] [Related]
10. Human Herpes Virus-8-Associated Multicentric Castleman's Disease in a Human Immunodeficiency Virus-Positive Patient with a Previous History of Kaposi's Sarcoma. Huang G; Low G J Clin Imaging Sci; 2015; 5():59. PubMed ID: 26664776 [TBL] [Abstract][Full Text] [Related]
11. Human herpes virus 8 replication during disseminated tuberculosis in a man with human immunodeficiency virus: a case report. Inoubli S; Toutous-Trellu L; Cathomas G; Oksenhendler E; Hirschel B; El Amari EB J Med Case Rep; 2009 Nov; 3():113. PubMed ID: 19946591 [TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease and HIV. Krause JR; Robinson SD; Vance EA Proc (Bayl Univ Med Cent); 2014 Jan; 27(1):28-30. PubMed ID: 24381398 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report. Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436 [TBL] [Abstract][Full Text] [Related]
14. HHV-8 Linked to Kaposi's Sarcoma and Castleman's Disease in HIV-1-infected patient: Case Report and Review of the Literature. Zaghdoudi A; Harrabi H; Tiouiri Benaissa H Int J Hematol Oncol Stem Cell Res; 2024 Apr; 18(2):202-205. PubMed ID: 38868814 [TBL] [Abstract][Full Text] [Related]
15. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701 [TBL] [Abstract][Full Text] [Related]
16. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920 [TBL] [Abstract][Full Text] [Related]
17. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253 [TBL] [Abstract][Full Text] [Related]
18. Coexistence of HHV-8-Associated Plasmacytic Multicentric Castleman Disease, Kaposi's Sarcoma, and Multiple Myeloma in a HIV-Negative Patient. Ismayilov R; Cinar OE; Ozdede M; Ozogul E; Malkan UY; Uner A; Gullu IH Eur J Case Rep Intern Med; 2024; 11(10):004876. PubMed ID: 39372151 [TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus-negative multicentric Castleman's disease coexistent with Kaposi's sarcoma on Hwang JP; Kim J; Park JM Mol Clin Oncol; 2019 Feb; 10(2):318-320. PubMed ID: 30680214 [TBL] [Abstract][Full Text] [Related]
20. Multicentric Castleman's Disease, Associated with Idiopathic Thrombocytopenic Purpura. Sood R; Taylor HC; Daw H Case Rep Hematol; 2013; 2013():269268. PubMed ID: 24198982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]